Overview

Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

This study will determine whether the drug betahistine increases focus and causes side effects in people with attention deficit hyperactivity disorder.

Phase:

Phase 1

Details

Lead Sponsor:

P2D, Inc.

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Betahistine